BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12462144)

  • 1. The TB structural genomics consortium: providing a structural foundation for drug discovery.
    Goulding CW; Apostol M; Anderson DH; Gill HS; Smith CV; Kuo MR; Yang JK; Waldo GS; Suh SW; Chauhan R; Kale A; Bachhawat N; Mande SC; Johnston JM; Lott JS; Baker EN; Arcus VL; Leys D; McLean KJ; Munro AW; Berendzen J; Sharma V; Park MS; Eisenberg D; Sacchettini J; Alber T; Rupp B; Jacobs W; Terwilliger TC
    Curr Drug Targets Infect Disord; 2002 Jun; 2(2):121-41. PubMed ID: 12462144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tuberculosis structural genomics consortium: a structural genomics approach to drug discovery.
    Musa TL; Ioerger TR; Sacchettini JC
    Adv Protein Chem Struct Biol; 2009; 77():41-76. PubMed ID: 20663481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA.
    Goulding CW; Perry LJ; Anderson D; Sawaya MR; Cascio D; Apostol MI; Chan S; Parseghian A; Wang SS; Wu Y; Cassano V; Gill HS; Eisenberg D
    Biophys Chem; 2003 Sep; 105(2-3):361-70. PubMed ID: 14499904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.
    Terwilliger TC; Park MS; Waldo GS; Berendzen J; Hung LW; Kim CY; Smith CV; Sacchettini JC; Bellinzoni M; Bossi R; De Rossi E; Mattevi A; Milano A; Riccardi G; Rizzi M; Roberts MM; Coker AR; Fossati G; Mascagni P; Coates AR; Wood SP; Goulding CW; Apostol MI; Anderson DH; Gill HS; Eisenberg DS; Taneja B; Mande S; Pohl E; Lamzin V; Tucker P; Wilmanns M; Colovos C; Meyer-Klaucke W; Munro AW; McLean KJ; Marshall KR; Leys D; Yang JK; Yoon HJ; Lee BI; Lee MG; Kwak JE; Han BW; Lee JY; Baek SH; Suh SW; Komen MM; Arcus VL; Baker EN; Lott JS; Jacobs W; Alber T; Rupp B
    Tuberculosis (Edinb); 2003; 83(4):223-49. PubMed ID: 12906835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural genomics approach to drug discovery for Mycobacterium tuberculosis.
    Ioerger TR; Sacchettini JC
    Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TB Structural Genomics Consortium: a decade of progress.
    Chim N; Habel JE; Johnston JM; Krieger I; Miallau L; Sankaranarayanan R; Morse RP; Bruning J; Swanson S; Kim H; Kim CY; Li H; Bulloch EM; Payne RJ; Manos-Turvey A; Hung LW; Baker EN; Lott JS; James MN; Terwilliger TC; Eisenberg DS; Sacchettini JC; Goulding CW
    Tuberculosis (Edinb); 2011 Mar; 91(2):155-72. PubMed ID: 21247804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing the structural coverage of tuberculosis drug targets.
    Baugh L; Phan I; Begley DW; Clifton MC; Armour B; Dranow DM; Taylor BM; Muruthi MM; Abendroth J; Fairman JW; Fox D; Dieterich SH; Staker BL; Gardberg AS; Choi R; Hewitt SN; Napuli AJ; Myers J; Barrett LK; Zhang Y; Ferrell M; Mundt E; Thompkins K; Tran N; Lyons-Abbott S; Abramov A; Sekar A; Serbzhinskiy D; Lorimer D; Buchko GW; Stacy R; Stewart LJ; Edwards TE; Van Voorhis WC; Myler PJ
    Tuberculosis (Edinb); 2015 Mar; 95(2):142-8. PubMed ID: 25613812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential impact of structural genomics on tuberculosis drug discovery.
    Arcus VL; Lott JS; Johnston JM; Baker EN
    Drug Discov Today; 2006 Jan; 11(1-2):28-34. PubMed ID: 16478688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium tuberculosis: a model system for structural genomics.
    Smith CV; Sacchettini JC
    Curr Opin Struct Biol; 2003 Dec; 13(6):658-64. PubMed ID: 14675542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Mycobacterium tuberculosis structural genomics: investigating potential chinks in the armor of a deadly pathogen.
    Chim N; McMath LM; Beeby M; Goulding CW
    Infect Disord Drug Targets; 2009 Nov; 9(5):475-92. PubMed ID: 19594421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based approaches to drug discovery against tuberculosis.
    Holton SJ; Weiss MS; Tucker PA; Wilmanns M
    Curr Protein Pept Sci; 2007 Aug; 8(4):365-75. PubMed ID: 17696869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Annotation of the Mycobacterium tuberculosis Proteome.
    Chandra N; Sandhya S; Anand P
    Microbiol Spectr; 2014 Apr; 2(2):. PubMed ID: 26105824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput crystallography at an affordable cost: the TB Structural Genomics Consortium Crystallization Facility.
    Rupp B
    Acc Chem Res; 2003 Mar; 36(3):173-81. PubMed ID: 12641474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural genomics as an approach towards understanding the biology of tuberculosis.
    Baker EN
    J Struct Funct Genomics; 2007 Sep; 8(2-3):57-65. PubMed ID: 17668294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural genomics of highly conserved microbial genes of unknown function in search of new antibacterial targets.
    Abergel C; Coutard B; Byrne D; Chenivesse S; Claude JB; Deregnaucourt C; Fricaux T; Gianesini-Boutreux C; Jeudy S; Lebrun R; Maza C; Notredame C; Poirot O; Suhre K; Varagnol M; Claverie JM
    J Struct Funct Genomics; 2003; 4(2-3):141-57. PubMed ID: 14649299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
    Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
    Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of inositol 1-phosphate synthase from Mycobacterium tuberculosis, a key enzyme in phosphatidylinositol synthesis.
    Norman RA; McAlister MS; Murray-Rust J; Movahedzadeh F; Stoker NG; McDonald NQ
    Structure; 2002 Mar; 10(3):393-402. PubMed ID: 12005437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the progress of Mycobacterium tuberculosis H37Rv structural genomics.
    Fang Z; van der Merwe RG; Warren RM; Schubert WD; Gey van Pittius NC
    Tuberculosis (Edinb); 2015 Mar; 95(2):131-6. PubMed ID: 25578513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.